These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20236303)

  • 21. Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry.
    Miyagi T; Koga M; Shiokawa Y; Nakagawara J; Hasegawa Y; Furui E; Kimura K; Kario K; Okuda S; Yamagami H; Okada Y; Nezu T; Maeda K; Endo K; Minematsu K; Toyoda K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1098-106. PubMed ID: 23063059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombolysis for Acute Minor Stroke: Outcome and Barriers to Management. Results from the RESUVAL Stroke Network.
    Laurencin C; Philippeau F; Blanc-Lasserre K; Vallet AE; Cakmak S; Mechtouff L; Cho TH; Ritzenthaler T; Flocard E; Bischoff M; El Khoury C; Nighoghossian N; Derex L
    Cerebrovasc Dis; 2015; 40(1-2):3-9. PubMed ID: 25998791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy.
    Kim DJ; Kim DI; Kim SH; Lee KY; Heo JH; Han SW
    Neuroradiology; 2005 Aug; 47(8):616-21. PubMed ID: 15983773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.
    Sobesky J; Frackowiak M; Zaro Weber O; Hahn M; Möller-Hartmann W; Rudolf J; Neveling M; Grond M; Schmulling S; Jacobs A; Heiss WD
    Cerebrovasc Dis; 2007; 24(1):56-65. PubMed ID: 17519545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and Efficacy of Intravenous Thrombolytic Therapy in Patients With Acute Posterior Circulation Stroke: A Single-Center Study.
    Zhu X; Wang N; Lin H; Zhang P; Chen L; Zhang M; Deng B; Wu T
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104537. PubMed ID: 31806454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
    Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
    Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses.
    Liao X; Wang Y; Pan Y; Wang C; Zhao X; Wang DZ; Wang C; Liu L; Wang Y;
    Stroke; 2014 Aug; 45(8):2354-8. PubMed ID: 25013020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome.
    Paliwal PR; Ahmad A; Shen L; Yeo LL; Loh PK; Ng KW; Chong VF; Ong BK; Venketasubramanian N; Sinha AK; Teoh HL; Bathla G; Chan BP; Sharma VK
    Cerebrovasc Dis; 2012; 33(5):446-52. PubMed ID: 22456065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
    Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
    JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.
    Nisar T; Hanumanthu R; Khandelwal P
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104360. PubMed ID: 31501036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and outcomes of intravenous thrombolysis in stroke mimics: a 6-year, single-care center study and a pooled analysis of reported series.
    Tsivgoulis G; Alexandrov AV; Chang J; Sharma VK; Hoover SL; Lao AY; Liu W; Stamboulis E; Alexandrov AW; Malkoff MD; Frey JL
    Stroke; 2011 Jun; 42(6):1771-4. PubMed ID: 21493900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of intravenous thrombolysis on stroke associated with atrial fibrillation.
    Padjen V; Jovanovic D; Berisavac I; Ercegovac M; Stefanovic Budimkic M; Stanarcevic P; Beslac Bumbasirevic L
    J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2199-2205. PubMed ID: 25018112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large-Vessel Occlusion Is Associated with Poor Outcome in Stroke Patients Aged 80 Years or Older Who Underwent Intravenous Thrombolysis.
    Zhu W; Xiao L; Lin M; Liu X; Yan B
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2712-2716. PubMed ID: 27522345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preceding Intravenous Thrombolysis in Patients Receiving Endovascular Therapy.
    Park HK; Chung JW; Hong JH; Jang MU; Noh HD; Park JM; Kang K; Lee SJ; Ko Y; Kim JG; Cha JK; Kim DH; Nah HW; Han MK; Kim BJ; Park TH; Park SS; Lee KB; Lee J; Hong KS; Cho YJ; Lee BC; Yu KH; Oh MS; Cho KH; Kim JT; Kim DE; Ryu WS; Choi JC; Kim WJ; Shin DI; Yeo MJ; Sohn SI; Lee JS; Lee J; Yoon BW; Bae HJ
    Cerebrovasc Dis; 2017; 44(1-2):51-58. PubMed ID: 28427054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged low-dose thrombolysis in posterior circulation stroke.
    Hametner C; Kellert L; Veltkamp R; Behrens L; Nagel S; Hacke W; Ringleb P
    Neurocrit Care; 2014 Aug; 21(1):114-8. PubMed ID: 24248735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are the results of intravenous thrombolysis trials reproduced in clinical practice? Comparison of observed and expected outcomes with the stroke-thrombolytic predictive instrument (STPI).
    Decourcelle A; Moulin S; Dequatre-Ponchelle N; Bodenant M; Rossi C; Girot M; Hénon H; Wiel E; Bordet R; Goldstein P; Pruvo JP; Cordonnier C; Leys D
    Rev Neurol (Paris); 2017 Jun; 173(6):381-387. PubMed ID: 28454980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous thrombolysis in stroke mimics: results from the SITS International Stroke Thrombolysis Register.
    Keselman B; Cooray C; Vanhooren G; Bassi P; Consoli D; Nichelli P; Peeters A; Sanak D; Zini A; Wahlgren N; Ahmed N; Mazya MV
    Eur J Neurol; 2019 Aug; 26(8):1091-1097. PubMed ID: 30793434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of early neurological deterioration after I.V - thrombolysis in acute ischaemic stroke patients - A hospital-based cohort study.
    Hansen CK; Christensen A; Havsteen I; Ovesen C; Christensen H
    Clin Neurol Neurosurg; 2018 Aug; 171():58-62. PubMed ID: 29843071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombectomy vs. Systemic Thrombolysis in Acute Embolic Stroke with High Clot Burden: A Retrospective Analysis.
    Meyne JK; Zimmermann PR; Rohr A; Riedel C; Hansen HC; Pulkowski U; Thie A; Holst T; Papengut F; Stingele R; Schepelmann K; Jansen O; Deuschl G; Binder A
    Rofo; 2015 Jul; 187(7):555-60. PubMed ID: 25831469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.